DT
IRWD icon

Diversified Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

Diversified Trust’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,574
Closed -$42.4K – 1096
2025
Q4 		$42.4K Hold
12,574
– – ﹤0.01% 1019
2025
Q3 		$16.5K Hold
12,574
– – ﹤0.01% 986
2025
Q2 		$9.02K Hold
12,574
– – ﹤0.01% 931
2025
Q1 		$18.5K Sell
12,574
-579
-4% -$1.38K ﹤0.01% 911
2024
Q4 		$58.3K Buy
13,153
+579
+5% +$2.35K ﹤0.01% 900
2024
Q3 		$51.8K Buy
+12,574
New +$67.6K ﹤0.01% 890
2021
Q4 		– Sell
-36,506
Closed -$477K – 872
2021
Q3 		$477K Hold
36,506
– – 0.02% 418
2021
Q2 		$470K Buy
+36,506
New +$418K 0.02% 414
2020
Q4 		– Sell
-12,552
Closed -$113K – 761
2020
Q3 		$113K Buy
12,552
+1,415
+13% +$14.1K 0.01% 607
2020
Q2 		$115K Buy
+11,137
New +$114K 0.01% 519

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Diversified Trust's IRWD Position: Q1 2026 in Review

Diversified Trust sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 12,574 shares — an estimated $42.4K sold.

Diversified Trust first reported a position in IRWD in Q2 2020 and held it in 10 quarters. The position peaked at $477K in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Diversified Trust reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Diversified Trust sold 12,574 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $42.4K.
  • Diversified Trust first reported a position in Ironwood Pharmaceuticals in Q2 2020 and held it in 10 quarters.
  • Diversified Trust's Ironwood Pharmaceuticals position peaked at $477K in Q3 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Diversified Trust's 13F filing for Q1 2026, filed 16 Apr 2026.